AGP Executive Report
Last update: 12 hours agoDEA Rescheduling Fight: The U.S. DOJ says prominent rescheduling opponents have “pocketbook interests,” arguing they’re protecting profits from drug-testing and cannabinoid pharma rather than public health, as the Schedule III push faces court challenges. Regulatory Process Watch: The DEA’s administrative hearing opened with the agency backing rescheduling, but critics say access was limited and pro-rescheduling voices were sidelined. Workplace Safety Concerns: Transportation and safety groups warn rescheduling could disrupt drug-testing for truck drivers and pilots, urging federal agencies to preserve testing rules. Medical Cannabis Custody Clash: New Mexico providers say a policy to take custody of substance-exposed newborns harms families, after the state’s directive was challenged in court. Public Health & Enforcement: Nova Scotia raised penalties for illegal cannabis sales and new offences target advertising and landlord involvement. Safety on the Ground: A UK driver was jailed after a 167mph chase and testing positive for cannabis, highlighting ongoing enforcement around impairment. THC Misuse Case: In Australia, a nurse was banned for spiking a backpacker’s tea with THC.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
